Company: CGCT
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001104659-25-034635
Chunk: 127

Company: Cartesian Growth Corp III
Filing Date: 2025-04-14
Form: S-1/A
Chunk 127
---
shares on a greater than one-to-one basis upon conversion of the founder shares at the time of our initial business combination. In addition,
because of the anti-dilution protection in the founder shares, any equity or equity-linked securities issued in connection with our initial
business combination would be disproportionately dilutive to our Class A ordinary shares.

The nominal purchase price paid by our initial shareholders for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our initial shareholders are likely to make a substantial profit on their investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.

We are offering our units at an offering price
of $10.00 per unit and the amount in our trust account is initially anticipated to be $10.00 per public share, implying an initial value
of $10.00 per public share. However, prior to this offering, our initial shareholders paid a nominal aggregate purchase price of $25,000
for the founder shares, or approximately $0.004 per share. As a result, the value of your public shares may be significantly diluted
upon the consummation of our initial business combination, when the founder shares are converted into public shares.

The following table shows the public shareholders’
and our initial shareholders’ investment per share and how these compare to the implied value of one Class A ordinary share
upon the completion of our initial business combination. The following table assumes that (i) our valuation is $191,000,000 (which
is the amount we would have in the trust account for our initial business combination assuming the underwriters’ over-allotment option
is not exercised and following payment of the underwriters’ deferred fee), (ii) no interest is earned on the funds held in
the trust account, (iii) no public shares are redeemed in connection with our initial business combination and (iv) all founder
shares are held by our initial shareholders upon completion of our initial business combination, and does not take into account other
potential impacts on our valuation at the time of the initial business combination, such as (i) the value of our public warrants
and private placement warrants, (ii) the trading price of our Class A ordinary shares, (iii) the initial business combination
transaction costs (other than the payment of $9,000,000 of deferred underwriting commissions), (iv) any equity